Proven Global Expertise
A wealth of experience in cancer
Our Scientific Affairs Group
The world-class and highly experienced Ellipses team use specialty experts within the Scientific Affairs Group to validate the science and clinical application of each asset. This provides an oncology-focused consensus that ensures in-licensed assets are appropriately developed.
The largest global panel of key opinion leaders in oncology
‘The patient sits at the forefront of our decision-making processes’
Crowd-sourced Expert Opinion
Unbiased, independent appraisal of the clinical data
Source
Introduce potential development assets
Early introduction to exciting new opportunities with clinician support offers Ellipses access to unique assets
Validate
Provide clinically relevant input on the science, indications and patient need for each asset
Independent analysis – removed from management influence – de-risks the development process
De-Risk
Supply independent clinical consensus to ensure we run the right trial in the right patient at the right time
SAG input obtained early in the process, understanding lead and side indications as well as patient perspectives and target groups
Join our Scientific Affairs Group